Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174169 | PMC |
| http://dx.doi.org/10.1016/j.jaip.2020.04.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to: "Neutrophil-Rich Infusion Site Reactions after Continuous Subcutaneous Application of Foslevodopa/Foscarbidopa".
Mov Disord
January 2025
Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease - Authors' reply.
Lancet Neurol
September 2024
University of Toulouse 3, University Hospital of Toulouse, INSERM, Clinical Investigation Center CIC1436, Department of Neurosciences and Department of Clinical Pharmacology, Toulouse, France; NS-Park/FCRIN Network, Toulouse, France.
Reply to: Letter to the Editor from Malik et al.: Acute kidney injury following subcutaneous meloxicam administration.
J Vet Pharmacol Ther
May 2024
Department of Comparative Biomedical Sciences, Royal Veterinary College, University of London, London, UK.
Reply: subcutaneous furosemide patch: heart failure decongestion 'from the comfort of your home'.
Eur Heart J Cardiovasc Pharmacother
May 2024
School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!